Andrew H Ko


Ontology type: schema:Person     


Person Info

NAME

Andrew H

SURNAME

Ko

Publications in SciGraph latest 50 shown

  • 2019-04 Referral frequency, attrition rate, and outcomes of germline testing in patients with pancreatic adenocarcinoma in FAMILIAL CANCER
  • 2018-07-30 Vitamin D Levels in Patients with Colorectal Cancer Before and After Treatment Initiation in JOURNAL OF GASTROINTESTINAL CANCER
  • 2018 Targeting the Tumor Microenvironment in CURRENT AND EMERGING THERAPIES IN PANCREATIC CANCER
  • 2017-03 A Patient with HIV-Associated Metastatic Anal Squamous Cell Carcinoma Receiving Multimodality Therapy with Curative Intent: Case Report and Review of the Literature in JOURNAL OF GASTROINTESTINAL CANCER
  • 2016-06 A phase 1 clinical trial of ASG-5ME, a novel drug-antibody conjugate targeting SLC44A4, in patients with advanced pancreatic and gastric cancers in INVESTIGATIONAL NEW DRUGS
  • 2016-02 A phase 1b study of the Akt-inhibitor MK-2206 in combination with weekly paclitaxel and trastuzumab in patients with advanced HER2-amplified solid tumor malignancies in BREAST CANCER RESEARCH AND TREATMENT
  • 2015-12 Randomized Phase II study of the safety, efficacy and immune response of GVAX pancreas (with cyclophosphamide) and CRS-207 with or without nivolumab in patients with previously treated metastatic pancreatic adenocarcinoma (STELLAR) in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2014-06 90Y Glass Microspheres for the Treatment of Unresectable Metastatic Liver Disease from Chemotherapy-Refractory Gastrointestinal Cancers: A Pilot Study in JOURNAL OF GASTROINTESTINAL CANCER
  • 2013-10 A phase 1 trial of imatinib, bevacizumab, and metronomic cyclophosphamide in advanced colorectal cancer in BRITISH JOURNAL OF CANCER
  • 2013-08 A multinational phase 2 study of nanoliposomal irinotecan sucrosofate (PEP02, MM-398) for patients with gemcitabine-refractory metastatic pancreatic cancer in BRITISH JOURNAL OF CANCER
  • 2012-12 A phase I trial of nab-paclitaxel, gemcitabine, and capecitabine for metastatic pancreatic cancer in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2012-08 A phase II randomized study of cetuximab and bevacizumab alone or in combination with gemcitabine as first-line therapy for metastatic pancreatic adenocarcinoma in INVESTIGATIONAL NEW DRUGS
  • 2011-04 Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy in NATURE MEDICINE
  • 2010-11 A phase II study of bevacizumab plus erlotinib for gemcitabine-refractory metastatic pancreatic cancer in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2008-10 A phase II study evaluating bevacizumab in combination with fixed-dose rate gemcitabine and low-dose cisplatin for metastatic pancreatic cancer: is an anti-VEGF strategy still applicable? in INVESTIGATIONAL NEW DRUGS
  • 2007-10 Pancreatic cancer and medical history in a population-based case–control study in the San Francisco Bay Area, California in CANCER CAUSES & CONTROL
  • 2005-07 Serum CA19-9 response as a surrogate for clinical outcome in patients receiving fixed-dose rate gemcitabine for advanced pancreatic cancer in BRITISH JOURNAL OF CANCER
  • 2003-01 CASE REPORT: Tumor-Associated Hypoglycemia from Metastatic Colorectal Adenocarcinoma: Case Report and Review of the Literature in DIGESTIVE DISEASES AND SCIENCES
  • 2002-06 Current and future strategies for combined-modality therapy in pancreatic cancer in CURRENT ONCOLOGY REPORTS
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
          {
            "affiliation": {
              "id": "https://www.grid.ac/institutes/grid.266102.1", 
              "type": "Organization"
            }, 
            "isCurrent": true, 
            "type": "OrganizationRole"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.412332.5", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.240473.6", 
            "type": "Organization"
          }
        ], 
        "familyName": "Ko", 
        "givenName": "Andrew H", 
        "id": "sg:person.0743422017.08", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0743422017.08"
        ], 
        "sdDataset": "persons", 
        "sdDatePublished": "2019-03-07T15:08", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-uberresearch-data-dimensions-researchers-20181010/20181011/dim_researchers/base/researchers_822.json", 
        "type": "Person"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.0743422017.08'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.0743422017.08'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.0743422017.08'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.0743422017.08'


     




    Preview window. Press ESC to close (or click here)


    ...